Keyphrases
Cardiac Resynchronization Therapy
99%
Left Bundle Branch Block
49%
Ventricular Arrhythmia
37%
Dyssynchrony
27%
Left Ventricular Ejection Fraction
20%
Hazard Ratio
19%
Left Ventricular Function
19%
Mechanical Dyssynchrony
18%
Confidence Interval
16%
Heart Failure
16%
Contraction Pattern
14%
Implantable Defibrillator
14%
Global Longitudinal Strain
14%
Echocardiography
12%
Echocardiographic
11%
Biventricular Pacing
11%
Right Ventricular
11%
Electrical Activation
11%
Ischemic Heart Disease
10%
Tissue Doppler Imaging
10%
Activation Delay
9%
High Normal
8%
Ischemic Cardiomyopathy
8%
Strain Echocardiography
8%
Right Ventricular Function
8%
Tissue Doppler
8%
Left-sided Infective Endocarditis
8%
Malignant Arrhythmia
8%
Acute Myocardial Infarction
8%
Atrial Fibrillation
8%
AIMS™
8%
Left Ventricular Remodeling
8%
All-cause Mortality
8%
Plasma Potassium
8%
QRS Duration
7%
Cross-correlation Analysis
7%
Clinical High Risk
7%
Myocardial Function
7%
Scar Tissue
7%
Infective Endocarditis
7%
Resynchronization
7%
Left Axis Deviation
7%
Heart Failure Hospitalization
7%
Inferior Wall
7%
High Risk
6%
Electrical Delay
6%
No Significant Difference
6%
Ventricular Activation
6%
Arrhythmia
6%
Sudden Cardiac Death
6%
Medicine and Dentistry
Cardiac Resynchronization Therapy
100%
Left Bundle Branch Block
50%
Implantable Automatic Defibrillator
34%
Heart Failure
33%
Heart Ventricle Arrhythmia
33%
Echocardiography
29%
Hazard Ratio
25%
Tissue Doppler Imaging
18%
Heart Left Ventricle Ejection Fraction
16%
Defibrillator
14%
Electrocardiogram
14%
Heart Function
11%
Heart Disease
11%
Ischemic Heart Disease
11%
Right Bundle Branch Block
10%
Ventricular Tachycardia
10%
QRS Interval
9%
Ventricular Fibrillation
8%
Ischemic Cardiomyopathy
8%
Bundle Branches
8%
Accelerometer
8%
Cardiac Dysrhythmia
8%
Cardiovascular Disease
8%
Scar Tissue
8%
Heart Ventricle Remodeling
8%
Ejection Fraction
7%
Biological Marker
7%
Long Term Survival
7%
Shock (Circulatory)
6%
Treatment Response
6%
Potassium Intake
5%
Mineralocorticoid Antagonist
5%
Randomized Controlled Trial
5%
Myocardial Disease
5%
QRS Complex
5%
Right Ventricular Function
5%
Patient Selection
5%
Proportional Hazards Model
5%
Systolic Heart Failure
5%
